loading
GCP Training in Canada

GCP Training in Canada

Good Clinical Practices for Clinical Research

Comprehensive online GCP training aligned with Health Canada Part C, Division 5 of the Food and Drug Regulations, ICH E6(R3), and international standards — trusted by Canadian clinical research professionals, sponsors, investigators, and CROs. Self‑paced. 21 CFR Part 11 compliant certificates. Inspection‑ready training records.

6+ GCP Courses | 21 CFR Part 11 Compliant Certs | 4+ Regulatory Frameworks | Health Canada & ICH Aligned


Regulatory Context

GCP Compliance in Canada: Health Canada, ICH & International Standards

Canada has a well‑established regulatory framework for Good Clinical Practice (GCP) that is governed by Health Canada Part C, Division 5 of the Food and Drug Regulations and aligned with the ICH E6(R3) Good Clinical Practice guideline. Health Canada adopted ICH E6(R3) effective April 1, 2026, making it the cornerstone of GCP compliance for clinical trials conducted in Canada.

Key Regulatory Frameworks:

Regulatory AuthorityFrameworkApplication
Health CanadaPart C, Division 5 of the Food and Drug RegulationsClinical trials involving human subjects
Health CanadaICH E6(R3) GCP (adopted April 1, 2026)Ethical and scientific quality standards
Health CanadaFood and Drugs ActLegislative authority
ICHICH E6(R3), E8(R1), E2 Series, E3, E9, E11(R1), E19International harmonisation standards

Key Requirements:

  • Health Canada Part C, Division 5 covers C.05.010(a) through (j), including scientific soundness, protocol compliance, quality systems, REB approval, qualified investigator (no more than one per site), medical supervision by QI, qualified personnel (education/training/experience), written informed consent, records and information (C.05.012), and GMP compliance for investigational drugs
  • Clinical Trial Applications (CTAs) and Amendments (CTA-As) must be submitted to Health Canada
  • Safety reporting obligations include AEs, SAEs, and SUSARs with specific timelines
  • Records must be retained for 15 years under C.05.012

Canada’s participation in ICH means that data generated in accordance with ICH E6(R3) GCP principles is accepted internationally, facilitating global clinical trial submissions.


Our Courses

GCP Training Courses — Health Canada & ICH Aligned

All courses are self‑paced, available online, and include 21 CFR Part 11 compliant certificates with verifiable IDs — accepted as documented training records during Health Canada and other regulatory inspections.


Most Popular for Canadian GCP Professionals

Good Clinical Practices (Health Canada)

Price: $249.00

This comprehensive training program provides clinical research professionals with the knowledge and practical skills required to conduct clinical trials in compliance with Health Canada Food and Drug Regulations (Part C, Division 5) and the ICH E6(R3) Good Clinical Practice (GCP) guideline.

The curriculum is aligned with Health Canada’s adoption of ICH E6(R3) effective April 1, 2026.

Included within scope:

  • Health Canada regulatory requirements for clinical trials (Part C, Division 5)
  • ICH E6(R3) Good Clinical Practice principles and Annex 1
  • Sponsor, Qualified Investigator (QI), and Research Ethics Board (REB) responsibilities
  • Clinical trial application (CTA) and amendment (CTA-A) processes
  • Informed consent requirements and participant protection
  • Safety reporting obligations (AEs, SAEs, SUSARs)
  • Data governance and record keeping requirements
  • Quality management and risk-based monitoring
  • Investigational product management and GMP compliance
  • Clinical trial inspections and enforcement

Learning Objectives:

  • Understand Health Canada’s regulatory authority for clinical trials
  • Interpret and apply Part C, Division 5 of the Food and Drug Regulations
  • Navigate the ICH E6(R3) Good Clinical Practice guideline
  • Distinguish between sponsor, investigator, and REB responsibilities
  • Prepare and submit Clinical Trial Applications (CTAs) and Amendments (CTA-As)
  • Ensure participant protection through informed consent and safety monitoring
  • Maintain essential documents and trial master files
  • Prepare for Health Canada GCP inspections

Target Audience:

  • Sponsors (commercial and non-commercial/academic)
  • Qualified Investigators (QIs) and Principal Investigators
  • Sub-Investigators and clinical research staff
  • Research Ethics Board (REB) members and administrators
  • Clinical Research Coordinators and study site personnel
  • Contract Research Organizations (CROs) and Service Providers
  • Clinical monitors and auditors
  • Regulatory affairs and quality assurance professionals
  • Pharmacovigilance professionals

Regulatory References:

  • Part C, Division 5 of the Food and Drug Regulations – Drugs for Clinical Trials Involving Human Subjects
  • Food and Drugs Act
  • ICH E6(R3) Good Clinical Practice guideline

Certification: Learners who successfully complete the program will receive a dated, traceable certificate that provides verifiable proof of their achievement for professional records.

Enroll in Good Clinical Practices (Health Canada)


GCP Global Auditor Certification

Price: $499.00

This training program defines the complete knowledge and performance requirements for personnel involved in clinical research to become certified global auditors for Good Clinical Practice (GCP).

The program integrates GCP requirements from ICH E6(R3), Health Canada Part C, Division 5 of the Food and Drug Regulations, and FDA regulations (21 CFR Parts 50, 56, 312, 314.50, and 314.80) with auditing practices based on ISO 19011:2026 for internal, second-party (vendor/CRO/site audits), and global regulatory compliance auditing.

Regulatory Frameworks Covered:

  • ICH E6(R3) – International ethical, scientific, and quality standard for designing, conducting, recording, and reporting clinical trials
  • Health Canada Part C, Division 5 – Canadian regulations for clinical trials, including C.05.010(a) through (j), C.05.011 (labelling), and C.05.012 (records with 15-year retention)
  • 21 CFR Part 50 – FDA protection of human subjects regulations
  • 21 CFR Part 56 – FDA Institutional Review Board regulations
  • 21 CFR Part 312 – FDA Investigational New Drug Application regulations
  • 21 CFR Part 314.50 – FDA New Drug Application content and format
  • 21 CFR Part 314.80 – FDA postmarketing reporting of adverse drug experiences

Auditing Practices Covered (ISO 19011:2026):

  • Principles of auditing (integrity, fair presentation, due professional care, confidentiality, independence, evidence-based approach, risk-based approach)
  • Audit programme management (objectives, risks, resources, procedures, implementation, monitoring, review, improvement)
  • Conducting an audit (initiation, preparation, execution, reporting, follow-up)
  • Remote auditing methods (virtual audits, technology considerations, security, contingency planning)
  • Competence and evaluation of auditors

Target Audience:

  • Clinical Research Professionals
  • Quality Assurance and Compliance Staff
  • Internal and External Auditors
  • Sponsors and CRO Personnel
  • Clinical Monitors
  • Regulatory Affairs Professionals

Prerequisites:

  • Completion of basic GCP awareness training of at least four hours or equivalent on‑the‑job experience
  • At least six months of experience in clinical research

Certification: Learners who successfully complete the program will receive a dated, traceable certificate that provides verifiable proof of their achievement for professional records.

Enroll in GCP Global Auditor Certification


Additional GCP Training Courses

Good Clinical Practices (ICH Focused)

Price: $149.00

This comprehensive training program provides an in-depth exploration of the ICH E6(R3) Good Clinical Practice guideline, the globally recognized standard for the ethical and scientific quality of clinical trial design, conduct, and reporting.

Finalized in January 2025, this latest revision represents a significant modernization of GCP principles, emphasizing a risk-based, proportionate approach to trial management and the integration of digital technologies.

Global Regulations and Guidelines Referenced:

  • ICH E6(R3): The International Council for Harmonization’s Guideline for Good Clinical Practice (adopted January 6, 2025)
  • ICH E8(R1): General Considerations for Clinical Studies
  • ICH E9 / E9(R1): Statistical Principles for Clinical Trials and Estimands
  • ICH E2 Series: Clinical Safety Data Management
  • ICH E3: Structure and Content of Clinical Study Reports
  • ICH E11(R1): Clinical Investigation of Medicinal Products in the Pediatric Population
  • ICH E19: A Selective Approach to Safety Data Collection

Target Audience:

  • Clinical Investigators and Sub-Investigators
  • Sponsor Personnel (Medical, Regulatory, Clinical Operations)
  • Clinical Research Associates (Monitors)
  • IRB/IEC Members and Coordinators
  • Data Management and Biostatistics Professionals
  • Quality Assurance and Compliance Staff
  • Clinical Trial Coordinators and Site Staff
  • Pharmacovigilance and Safety Specialists
  • Regulatory Affairs Professionals
  • Clinical Research Organization (CRO) Personnel

Certification: Learners who successfully complete the program will receive a dated, traceable certificate that provides verifiable proof of their achievement for professional records.

Curriculum: 10 Sections – 10 Lessons – Lifetime Access

Enroll in Good Clinical Practices (ICH Focused)


ISO 19011:2026 – Auditing Management Systems

Price: $199.00

This comprehensive training program is designed to provide individuals with a thorough understanding of ISO 19011:2026, “Guidelines for Auditing Management Systems.”

The program covers all aspects of the standard, including the principles of auditing, managing an audit programme, conducting management system audits, and evaluating the competence of individuals involved in the audit process.

Objectives:

  • Understand the Purpose and Scope of ISO 19011:2026
  • Apply the Seven Principles of Auditing
  • Establish and Manage an Audit Programme
  • Plan and Prepare for Audits
  • Conduct Auditing Activities Effectively
  • Prepare and Distribute Audit Reports
  • Complete Audits and Conduct Follow-up
  • Evaluate and Maintain Auditor Competence
  • Apply Remote Auditing Methods

Target Audience:

  • Internal Auditors
  • Audit Programme Managers
  • Quality Managers and Quality Professionals
  • Management System Practitioners
  • Second-Party Auditors
  • Consultants
  • Individuals Preparing for Auditor Certification

Certification: Learners who successfully complete the program will receive a dated, traceable certificate that provides verifiable proof of their achievement for professional records.

Enroll in ISO 19011:2026 – Auditing Management Systems


HIPAA Clinical Data Privacy, Security & Compliance

Price: $249.00

This training program is designed to provide organizations and individuals with a comprehensive understanding of the legal, regulatory, and operational requirements for protecting health information in clinical research and healthcare delivery settings.

Included within scope:

  • Protection of Protected Health Information (PHI) and Electronic Protected Health Information (ePHI)
  • HIPAA Privacy, Security, and Breach Notification Rules
  • Good Clinical Practice (GCP) under ICH E6(R3)
  • Clinical data integrity and source documentation requirements
  • Security controls for information systems and cloud environments
  • Regulatory compliance frameworks including FDA, NIST, and ISO standards
  • Incident management, breach response, and risk assessment

Target Audience:

  • Covered Entities under HIPAA
  • Business Associates and their subcontractors
  • Clinical Research Professionals
  • Security and Compliance Professionals

Regulatory References:

  • HIPAA Privacy Rule – 45 CFR Part 160 and Part 164
  • HIPAA Security Rule – 45 CFR Part 160 and Part 164
  • HIPAA Breach Notification Rule – 45 CFR Part 164
  • 21 CFR Part 11 – Electronic Records; Electronic Signatures
  • ICH E6(R3) Guideline for Good Clinical Practice

Enroll in HIPAA Clinical Data Privacy, Security & Compliance


Who Needs GCP Training in Canada?

GCP training is a regulatory requirement for all personnel involved in the conduct of clinical trials of drugs in human participants in Canada.

Sponsors & CROs

  • Commercial and non-commercial/academic sponsors
  • Contract Research Organizations (CROs) and Service Providers

Investigators & Site Staff

  • Qualified Investigators (QIs) and Principal Investigators
  • Sub-Investigators and clinical research staff
  • Clinical Research Coordinators and study site personnel
  • Research nurses and healthcare professionals

Ethics & Compliance

  • Research Ethics Board (REB) members and administrators
  • Quality assurance professionals
  • Regulatory affairs professionals

Clinical Operations

  • Clinical monitors and auditors
  • Data managers and biostatisticians
  • Pharmacists and investigational product handlers
  • Pharmacovigilance professionals

GCP Inspections, Compliance Risk & Training Records

What Happens When GCP Training Falls Short

Health Canada conducts GCP inspections of clinical trial sites, sponsors, and CROs to verify compliance with Part C, Division 5 of the Food and Drug Regulations and ICH E6(R3) GCP. Inspection findings can have serious consequences:

  • Non-compliance statements affecting the acceptance of clinical trial data
  • Rejection of clinical data in regulatory submissions (NDS, NOC)
  • Clinical trial holds or suspensions
  • Legal action under the Food and Drugs Act

Common Health Canada GCP inspection observations include:

  • Inadequate personnel training and documentation
  • Insufficient informed consent processes
  • Poor source documentation and data integrity issues
  • Inadequate safety reporting and investigational product accountability

Inspection‑Ready Training Records

Our 21 CFR Part 11 compliant certificates provide auditable, documented training records that Health Canada inspectors accept during inspections.

  • Unique verifiable certificate ID — check at gxptrainings.com/verify-certificate/
  • Includes completion date, course name, and assessment score
  • Downloadable PDF — upload to any QMS or LMS
  • Accepted by Health Canada inspectors
  • Satisfies Health Canada Part C, Division 5 and ICH E6(R3) training requirements

Why Choose GxP Trainings for GCP

FeatureGxP Trainings
Health Canada Part C, Division 5 aligned
ICH E6(R3) GCP aligned
FDA 21 CFR Parts 50, 56, 312 covered
ISO 19011 auditing principles covered
21 CFR Part 11 compliant certificate
Self‑paced — study on your schedule
Instant certificate download
Verifiable certificate ID
Group / corporate enrollment

Frequently Asked Questions

Q: Is online GCP training accepted by Health Canada?
Yes. Health Canada does not mandate a specific training delivery format. What matters is that training is documented, role‑appropriate, and effective. Our 21 CFR Part 11 compliant certificates provide verifiable proof of training that Health Canada inspectors accept during inspections.

Q: When did Health Canada adopt ICH E6(R3)?
Health Canada adopted ICH E6(R3) effective April 1, 2026.

Q: What is the record retention requirement for clinical trials in Canada?
Under C.05.012 of the Food and Drug Regulations, records must be retained for 15 years.

Q: What are the prerequisites for the GCP Global Auditor Certification course?
Completion of basic GCP awareness training of at least four hours or equivalent on‑the‑job experience, and at least six months of experience in clinical research.

Q: Do you offer group discounts for Canadian companies?
Yes. We offer corporate and group enrollment options for teams of all sizes. Contact us for a custom quote.

Q: How long do I have access to the course?
All courses include lifetime access — study at your own pace, on your own schedule.

Q: Are the certificates verifiable?
Yes. Each certificate includes a unique verifiable ID that can be checked at gxptrainings.com/verify-certificate/


Canada GCP Compliance Summary

Health Canada requires that clinical trials involving human subjects be conducted in compliance with Part C, Division 5 of the Food and Drug Regulations and ICH E6(R3) Good Clinical Practice.

Health Canada Part C, Division 5 — Clinical Trials Involving Human Subjects

Key Sections:

  • C.05.010(a) through (j): Scientific soundness, protocol compliance, quality systems, REB approval, qualified investigator, medical supervision, qualified personnel, written informed consent, records and information, GMP compliance
  • C.05.011: Labelling requirements for investigational drugs
  • C.05.012: Records and information retention — 15 years

ICH E6(R3) Good Clinical Practice

ICH E6(R3) represents a significant modernization of GCP principles, emphasizing a risk-based, proportionate approach to trial management and the integration of digital technologies. Health Canada adopted ICH E6(R3) effective April 1, 2026.


All GxP Trainings courses referenced above are designed to align with Health Canada Part C, Division 5 of the Food and Drug Regulations, ICH E6(R3) Good Clinical Practice, and international GCP standards.

Author

  • GCP Subject Matter Expert (SME)

    Sarah M. Richardson is a Senior Good Clinical Practices (GCP) Subject Matter Expert (SME) with 28+ years of experience supporting global clinical development programs across Phase I–IV clinical trials.